In our series of letters from African journalists, Joseph Warungu looks at the safety of the heterologous Ebola vaccination regimen in healthy and HIV-infected adults in Kenya and Cote d’Ivoire, Uganda and Burkina Faso.
Source: journals.plos.orgPublished on 2021-10-29
Related news
- Amid Pyrophosphate Shortage , ASNC Issues Statement on How to Use HMDP as an Alternative Radiopharmaceutical in Cardiac Amyloidosis Imaging
- ASNC Issues Statement on How to Use HMDP as an Alternative Radiopharmaceutical in Cardiac Amyloidosis Imaging
- Safety and immunogenicity of 2 - dose heterologous Ad26 . ZEBOV , MVA - BN - Filo Ebola vaccination in children and adolescents in Africa : A randomised , placebo - controlled , multicentre Phase II clinical trial
- Local officials hope national opioid settlement will help curb crisis